What are you looking for?
Our expertise in Pharma
Innovations in the Pharmacy sector, for example, innovations relating to drug repurposing and (re) development of medications ensure a continuous stream of innovations within this sector. NLO's Pharma teams consist of attorneys with diverse, relevant specialisations. Our IP specialists have acquired experience in either business or research institutes before working at NLO. They are familiar with the ins & outs in Pharmacy, including current developments and regulations.
Our clients
NLO serves clients in the Pharma sector in which our experts can stand by your side to advise your company and innovations about the importance of patents and intellectual property.
WHAT OUR CLIENTS SAY ABOUT WORKING WITH NLO
Article
What if an existing medicine for diabetes can also be used for the untreatable disease Alzheimer?
Publication in the FD: Researchers regularly develop new purposes for existing drugs. This so called ‘drug repurposing’ may allow patients to access a therapy for the first time or improve current treatment. In addition, the development process can be faster than for a newly developed drug and costs are often lower and patients may get access to therapy sooner. Patent attorney Barend Bouma explains, read the complete article in the FD paper about drug repurposing (p5).
Article BiotechNews
Drug repurposing p. 28-29
NLO colleagues Mari Korsten, Jaap Mannaerts and Barend Bouma wrote an interesting article for BiotechNews about “Unlocking the promise of drug repurposing”. Clinical programs directed to drug repurposing bear the promise of providing new therapies for yet non-treatable diseases based on available therapeutics. First and foremost, by drug repurposing, new patients may get access to therapy perhaps for the first time, or current treatment may be improved. Read the complete article by NLO experts here (page 28-29):
Opportunities for the treatment of rare diseases with available medicines
Patent Attorneys
IP Specialists in Pharma
Patent Attorneys
IP Specialists in Pharma
